Medical Bulletin 15/April/2026

Here are the top medical news for today:

1.3 billion Affected in 2023, Liver Disease Burden Set to Hit 1.8 billion by 2050: Lancet study

A silent liver disease is spreading at an alarming pace—and most people don’t even know they have it.

A new study published in The Lancet Gastroenterology and Hepatology reveals that around 1.3 billion people worldwide were living with Metabolically Associated Steatotic Liver Disease (MASLD) in 2023—a staggering 143% increase since 1990. Drawing on data from the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2023, researchers project that cases could surge to nearly 1.8 billion by 2050.

The rapid rise is largely driven by population growth and modern lifestyle factors, including increasing rates of obesity, high blood sugar, and sedentary behavior. Regions such as North Africa and West Asia continue to report disproportionately higher prevalence, highlighting geographic disparities in risk.

Despite this sharp increase in cases, the overall disease burden—measured in years lost to disability or premature death—has remained relatively stable. This suggests that improvements in early diagnosis, treatment, and disease management may be helping people live longer with the condition. However, experts warn that a growing number of patients could still translate into more cases progressing to severe complications, including liver cirrhosis and liver cancer.

Another concerning trend is the rising incidence of MASLD among younger adults, particularly in low- and middle-income countries. Rapid urbanisation, dietary changes, and reduced physical activity are accelerating the spread of metabolic disorders in these populations.

In 2023, MASLD affected an estimated 16.1% of the global population, with prevalence rates increasing significantly over the past three decades. While the condition often remains silent in its early stages, its long-term consequences can be severe if left unmanaged.

Experts are calling for stronger public health policies, increased awareness, and early lifestyle interventions to curb its growing impact and prevent future complications.

REFERENCE: Kim S, Oh J, Shin J et al.; Global burden of metabolic dysfunction-associated steatotic liver disease, 1990–2023, and projections to 2050: a systematic analysis for the Global Burden of Disease Study 2023; The Lancet Gastroenterology & Hepatology, 2026; DOI: 10.1016/S2468-1253(26)00011-7

Scientists Discover Spice Combination That Boosts Anti-Inflammatory Effects Up to 100-Fold

What if the secret to fighting inflammation isn’t a single “superfood,” but the way everyday ingredients work together?

A new study published in the journal Nutrients reveals that combining natural compounds found in common foods like chili peppers, mint, and eucalyptus can dramatically amplify their anti-inflammatory effects—by hundreds of times compared to when they are used individually. The research, led by Gen-ichiro Arimura at the Tokyo University of Science, sheds light on how plant-based diets may influence inflammation at a molecular level.

Chronic inflammation is a silent driver of many serious diseases, including type 2 diabetes, heart disease, obesity, arthritis, and cancer. It is regulated by immune cells such as macrophages, which release signaling molecules called cytokines. While many herbs and spices are known to contain anti-inflammatory phytochemicals, their effects in isolation often require doses higher than what typical diets provide—raising questions about their real-world impact.

To explore this, researchers tested compounds like capsaicin (from chili peppers), menthol (from mint), and 1,8-cineole (from eucalyptus) on immune cells under inflammatory conditions. While capsaicin alone showed the strongest effect, the most striking results came from combinations. When paired with menthol or cineole, its anti-inflammatory action increased several hundred-fold.

The study found that this synergy occurs because different compounds activate distinct cellular pathways. Menthol and cineole act through TRP channels, which regulate calcium signaling, while capsaicin works through a separate mechanism. Together, they create a more powerful and coordinated anti-inflammatory response.

These findings suggest that the benefits of plant-rich diets may stem from the interaction of multiple compounds rather than isolated nutrients. This could pave the way for more effective functional foods, supplements, and therapeutic formulations.

While further research in humans is needed, the study offers compelling evidence that combining natural food compounds may be a powerful strategy for managing inflammation and supporting long-term health.

REFERENCE: Kaori Terashita, Masato Kohakura, Katsura Sugawara, Shinichi Miyagawa, Gen-ichiro Arimura. Functional Phytochemicals Cooperatively Suppress Inflammation in RAW264.7 Cells. Nutrients, 2026; 18 (3): 376 DOI: 10.3390/nu18030376

Study Explains Why Eating an Apple a Day May Affect Individuals Differently

What if eating an apple a day doesn’t work the same way for everyone?

A new study published in Frontiers in Nutrition suggests that the health benefits of apples may depend on your gut microbiome. Researchers found that individual “enterotypes”—distinct gut bacterial profiles—can influence how the body responds to daily apple consumption, highlighting the growing importance of personalized nutrition.

The 12-week trial involved 38 Japanese adults who consumed one apple daily. Participants were grouped into three gut types: Bacteroidaceae, Ruminococcaceae, and Prevotellaceae. While overall health markers such as BMI, blood sugar, and cholesterol showed no significant changes across the group, deeper analysis revealed striking differences at the microbial level.

Participants in the ET1 group experienced a significant increase in short-chain fatty acids (SCFAs)—beneficial compounds produced by gut bacteria during fiber fermentation. SCFAs, including acetate, propionate, and butyrate, are known to support gut health, reduce inflammation, and improve metabolic function. However, these benefits were not observed in the other two groups, suggesting that baseline gut composition plays a key role in determining dietary impact.

Apples are rich in fiber and polyphenols, particularly compounds like procyanidins, which are known to influence gut bacteria. Interestingly, the study found that while SCFA production increased in some individuals, the actual abundance of specific bacteria did not change significantly. This indicates that apples may enhance microbial activity rather than simply altering bacterial populations.

The findings support the concept of “precision nutrition,” where dietary recommendations are tailored to unique biological makeup. Rather than a one-size-fits-all approach, future nutrition strategies may consider gut microbiome profiles to optimize health outcomes.

Ultimately, it reinforces a key message: the benefits of healthy foods like apples may vary from person to person, depending on what’s happening inside the gut.

REFERENCE: Shoji, T., et al. (2026). Apple consumption is associated with obesity- and lipid-related parameters and gut microbiota profiles across enterotypes: 12-week single-blind trial in Japanese adults. Frontiers in Nutrition, 13. DOI - 10.3389/fnut.2026.1797920. https://www.frontiersin.org/journals/nutrition/articles/10.3389/fnut.2026.1797920/full